Evidence snapshot: The strongest human evidence comes from a 2-year randomized controlled trial in 65 healthy older adults (Nass et al., 2008, Annals of Internal Medicine) showing sustained GH/IGF-1 increases and preserved fat-free mass, plus an earlier short-term human polysomnography study on sleep (Copinschi et al., 1997, Neuroendocrinology, PMID 9349662)
[DOI] [PubMed] [Google Scholar] 6.Steffensen S
Although strong preclinical evidence indicates the important relationship between diabetes and PDAC, there is a lack of attention to the longitudinal glycemia management in PDAC patients
it moves through a cycle, with a long growth phase, a short transition phase, and a rest phase before shedding happens
What is D64.9: Anemia, Unspecified In the medical billing industry, D64.9 is a billable ICD-10 code to signify anemia, unspecified
As such, it makes sense that low IGF-1 levels may cause health problems like diabetes